MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00520-025-09746-6

Медицинская библиотека · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025

Clinical outcomes in patients with cancer and Gram-negative bloodstream infection: impact of carbapenem resistance.

Volkow-Fernández Patricia, Pineda-Benitez Saraí, Alatorre-Fernández Pamela, Islas-Muñoz Beda, Velázquez-Acosta Consuelo, Cornejo-Juárez Patricia

СтатьяПеревод в очереди

Аннотация

PURPOSE: To describe the outcome of cancer patients who present bloodstream infections (BSIs) by Gram-negative bacteria (GNB) and to analyze the impact of carbapenem resistance.

METHODS

A retrospective study from 2021 to 2023 at a tertiary care oncologic center in Mexico. The study describes demographic, clinical, and microbiological characteristics in oncological patients with GNB-BSI.

RESULTS

During the study period, 1348 episodes of bacteremia were included. There were 703 women (52.1%), with a mean age of 50.5 ± 16.3 years. Five hundred thirty-six (39.7%) events were reported in patients with hematological malignancies (HM) and 814 (60.3%) in patients with solid tumors, having differences between both groups in age, gender, neutropenia, and type of BSI. Polymicrobial bacteremia was documented in 111 patients; 1468 GNB were identified. Nine hundred forty-five were classified as susceptible (64.4%), 417 (28.4%) were 3rd generation cephalosporins-resistant (C3R), and 106 (7.2%) were carbapenem-resistant (CR). CR episodes were most frequent in patients with HM, with severe neutropenia, and with > 2 previous episodes of BSI. Mortality at 30 days for the whole group was 21.1% and 37.5% for patients with CR strains. Multivariate analysis for 30-day mortality revealed that age > 60 years, severe neutropenia, bloodstream infection (BSI) other than catheter-related, polymicrobial BSI, ICU admission, CR strains, and inappropriate antimicrobial treatment were identified as risk factors.

CONCLUSIONS

Oncology patients, particularly those with HM, are a high-risk group for CR-GNB. These patients have a high mortality. Appropriate antimicrobial treatment is crucial for reducing mortality.

Для цитирования: Volkow-Fernández Patricia, Pineda-Benitez Saraí, Alatorre-Fernández Pamela, Islas-Muñoz Beda, Velázquez-Acosta Consuelo, Cornejo-Juárez Patricia. Clinical outcomes in patients with cancer and Gram-negative bloodstream infection: impact of carbapenem resistance.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025. DOI: 10.1007/s00520-025-09746-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.